D. E. Shaw & Co., Inc. Igm Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 97,716 shares of IGMS stock, worth $868,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,716

Holding current value

$868,695

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $209,431 - $589,610	-33,349 Reduced 25.44%	97,716 $1.62 Million
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $246,742 - $434,735	37,902 Added 40.68%	131,065 $900,000
Q1 2024 May 15, 2024	BUY	$8.68 - $17.36 $398,568 - $797,136	45,918 Added 97.19%	93,163 $899,000
Q4 2023 Feb 14, 2024	SELL	$3.94 - $8.79 $112,955 - $252,000	-28,669 Reduced 37.77%	47,245 $392,000
Q3 2023 Nov 14, 2023	SELL	$6.66 - $10.64 $663,815 - $1.06 Million	-99,672 Reduced 56.77%	75,914 $633,000
Q2 2023 Aug 14, 2023	SELL	$8.86 - $14.0 $1.32 Million - $2.09 Million	-148,951 Reduced 45.9%	175,586 $1.62 Million
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $897,895 - $1.68 Million	-65,349 Reduced 16.76%	324,537 $4.46 Million
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $814,462 - $1.37 Million	52,716 Added 15.63%	389,886 $6.63 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $965,538 - $1.69 Million	62,616 Added 22.81%	337,170 $7.67 Million
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $1.48 Million - $2.83 Million	-111,158 Reduced 28.82%	274,554 $4.95 Million
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $3.4 Million - $7.54 Million	253,614 Added 191.99%	385,712 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $3.21 Million - $7.73 Million	116,413 Added 742.19%	132,098 $3.87 Million
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $767,748 - $1.06 Million	-11,675 Reduced 42.67%	15,685 $1.03 Million
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $1.64 Million - $2.74 Million	-28,331 Reduced 50.87%	27,360 $2.28 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $1.77 Million - $3 Million	24,753 Added 80.01%	55,691 $4.27 Million
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $1.47 Million - $3.56 Million	30,938 New	30,938 $2.73 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $258M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account